Visium Asset Management’s Novartis NVS Stock Holding History

Visium Asset Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-34,923	Closed	-$2.27M	–	445
2016 Q1	$2.27M	Buy	+34,923	New	+$2.38M	0.04%	373
2015 Q3	–	Sell	-3,712	Closed	-$327K	–	1101
2015 Q2	$327K	Buy	+3,712	New	+$341K	﹤0.01%	770
2015 Q1	–	Sell	-3,125	Closed	-$260K	–	1144
2014 Q4	$260K	Sell	3,125 -19,548	-86%	-$1.62M	﹤0.01%	911
2014 Q3	$1.91M	Sell	22,673 -47,634	-68%	-$3.85M	0.03%	477
2014 Q2	$5.7M	Buy	70,307 +18,820	+37%	+$1.48M	0.09%	207
2014 Q1	$3.92M	Sell	51,487 -124,349	-71%	-$9.06M	0.06%	274
2013 Q4	$12.7M	Buy	175,836 +63,565	+57%	+$4.42M	0.25%	80
2013 Q3	$7.72M	Buy	112,271 +31,772	+39%	+$2.1M	0.18%	98
2013 Q2	$5.1M	Buy	+80,499	New	+$5.24M	0.12%	127

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Visium Asset Management's NVS Position: Q2 2016 in Review

Visium Asset Management sold out of Novartis (NVS) in Q2 2016, closing a stake of 34,923 shares — an estimated $2.27M sold.

Visium Asset Management first reported a position in NVS in Q2 2013 and held it in 9 quarters. The position peaked at $12.7M in Q4 2013. 879 funds tracked by Wall St. Rank hold NVS as of Q2 2016.

Visium Asset Management reported no remaining Novartis position as of Q2 2016 after selling out during the quarter.
Visium Asset Management sold 34,923 Novartis shares in Q2 2016, an estimated $2.27M.
Visium Asset Management first reported a position in Novartis in Q2 2013 and held it in 9 quarters.
Visium Asset Management's Novartis position peaked at $12.7M in Q4 2013.
879 funds tracked by Wall St. Rank held Novartis as of Q2 2016.

Based on Visium Asset Management's 13F filing for Q2 2016, filed 12 Aug 2016.